SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis.

This review article demonstrates how COVID-19 pandemic is causing serious damage to the sector of liver disease, which has quickly lost the beneficial effects of years of study, research, and clinical and technological application, as well as considerable financial investments.